Navigation Links
Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma
Date:12/10/2007

SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN), today announced that Wyeth Pharmaceuticals has initiated a Phase I/II clinical trial of TRU-015, Trubion's lead Small Modular ImmunoPharmaceutical (SMIP(TM)) drug candidate, for the treatment of non-Hodgkin's lymphoma (NHL). The nonrandomized, open label, uncontrolled, single-group assignment clinical trial is designed to evaluate the safety and efficacy of TRU-015 in subjects with NHL. Trubion is co-developing TRU-015 and other CD20-directed therapies with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).

"We believe that TRU-015 may be a valuable tool in the treatment of NHL, and we are looking forward to working with Wyeth as this development program moves forward," said Peter Thompson, M.D., FACP, president, chief executive officer and chairman of Trubion.

TRU-015 Phase I/II Clinical Trial Protocol

The Phase I/II clinical trial is expected to enroll approximately 120 NHL subjects who have undergone two or more prior therapies and have relapsed or refractory disease. Efficacy will be evaluated according to disease response and progression status per the International Response Criteria for NHL. Participants will receive an escalating dose of four weekly infusions of TRU-015. Once a maximum tolerated dose is confirmed, or once a maximum dose to be studied is determined to be safe and well tolerated, an expanded cohort of subjects with relapsed follicular NHL will be evaluated for efficacy.

Trubion
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... VILLAGE, Calif. , July 27, 2015 ... Inc. (NASDAQ: KYTH ) today announced that the ... of the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... pending acquisition of KYTHERA.  Logo - ... each of Allergan and KYTHERA filed a Pre-Merger Notification ...
(Date:7/27/2015)...  SeraCare Life Sciences, a leading partner to ... 2015 AACC Annual Meeting today that it has ... a biotechnology company that develops, markets and sells ... with ViveST™ allow sample collection, transport and storage ... terms of the agreement, the two firms will ...
(Date:7/27/2015)... 2015 Research and ... of the "Cardiometabolic Drug News Issue" ... pricing is in line with our existing view ... product,s commercial appeal. However, contraindications, side effects, and ... a sizeable share of the fast-acting insulin market. ...
Breaking Medicine Technology:Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3
... MYL ) today obtained a temporary restraining ... of New Jersey that prohibits Apotex from "using, offering ... or importing" all three strengths of a generic version ... Tablets, 12.5 mg, 25 mg and 37.5 mg. The ...
... (Pink Sheets: SNDY ) is pleased to announce ... on Tuesday, September 28, 2010 at 9:00am EDT. The meeting ... 25 Allied Drive, Dedham, MA 02026. The agenda for the ... of Directors and approve the appointment of Fred Schiemann, CPA, ...
Cached Medicine Technology:Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010 2
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is ... extreme caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent ... July 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in ...
(Date:7/28/2015)... ... July 28, 2015 , ... Coco Libre announced ... Eco-Excellence Award for the Nutrition Beverage category. Established by NCW Magazine, the Awards ... that stand out for their social and environmental sustainability. , “This award is ...
(Date:7/28/2015)... ... ... Maryland Brain & Spine has adopted a new name – Maryland Brain, ... treatment techniques, and additional state-of-the art online resources for patients. MBSP ... brain and spine conditions. , “Adding the word ‘pain’ may not seem like ...
(Date:7/28/2015)... ... ... Intellitec Solutions has been named by Accounting Today magazine as a Top ... Software is a look at the firms that have done the most with the ... in 2015 for Intellitec Solutions, following being named to Bob Scott’s Insights list of ...
(Date:7/28/2015)... ... 28, 2015 , ... North American Seminars will present seventeen ... 2015 . These seventeen courses are pre-approved for CME credit for Physical ... in the Older Adult , August 22, 2015 - August 23, 2015 ...
Breaking Medicine News(10 mins):Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8
... Increases Urgency for Helping ... Holidays ,Heart Healthy, CHICAGO, Dec. 6 A new ... indicates overweight and obesity in,childhood and adolescence substantially increases future ... nation,s obesity,epidemic are yet to come. YMCAs nationwide offer an ...
... in Compensation and Benefits, MINNEAPOLIS, Dec. 6 ... McGuire, today agreed to,terms with the UnitedHealth Special Litigation ... $420 million in stock options and other,compensation to settle ... tenure as CEO of the company, in addition to ...
... own and operate clinics in two Longs Drugs in ... ... LDG ) is pleased to announce today that it plans,to lease space ... Drugs by the end of calendar 2007. The Longs Drugs in,the Mililani Town ...
... the Abramson Cancer Center of the University of Pennsylvania ... sports or individual physical activity are less likely to ... the protective effect of participation extends at least three ... girls do not derive the same level of protection ...
... by Congress to Avoid 35% Cut in Diabetes Research, WASHINGTON, Dec. 6 , ... Thursday, December 6th, 2007 ... Galaxy 25 ... Transponder 14 ...
... the Country Appeal to the ... MRI, MALVERN, Pa., Dec. 6 For anyone who has ... find the time,now,s your chance to make a big impact on ... video posting period in Siemens first-ever,"Win an MRI" contest has closed. ...
Cached Medicine News:Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 2Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 3Health News:YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season 4Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 2Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 3Health News:Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics 2Health News:Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics 3Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 2Health News:Participation in organized high school activities lowers risk of smoking 3 years after graduation 3Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 2Health News:The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens' Newest MRI Technology 3
... wristband that provides automated ID verification for ... efficiency and accuracy. Meets healthcare patient ID ... risk of data left on ribbons (HIPAA) ... (FDA). Also available with UV varnish, which ...
... DataMate Laser Sheeted Wristband ... of laser-printable sheets with ... and laser labels that ... wristbands clear, fold-over protective ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... for use in settings, such ... where you may need a ... easy to apply but very ... width is increased to 1 ...
Medicine Products: